These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9874594)

  • 21. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of tuberculosis].
    Broquié G
    Soins; 1982 May; 27(9):31-4. PubMed ID: 6920111
    [No Abstract]   [Full Text] [Related]  

  • 23. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 26. Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
    Dosumu EA
    Niger Postgrad Med J; 2002 Mar; 9(1):34-7. PubMed ID: 11932759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fundamental principles of diagnosis, differential diagnosis and treatment of ocular tuberculosis].
    Ustinova EI
    Vestn Oftalmol; 2001; 117(3):38-41. PubMed ID: 11521436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
    Warndorff DK; Yates M; Ngwira B; Chagaluka S; Jenkins PA; Drobniewski F; Pönnighaus JM; Glynn JR; Fine PE
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):752-7. PubMed ID: 10949327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
    Hetrick G; Humarau H
    Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
    Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
    Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical comparisons of 1,498 chronic renal failure patients with and without tuberculosis.
    Yuan FH; Guang LX; Zhao SJ
    Ren Fail; 2005; 27(2):149-53. PubMed ID: 15807178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of 113 cases with severe and mild forms of extrapulmonary tuberculosis].
    Turunç T; Habeşoğlu MA; Demiroğlu YZ; Karataşli M; Sen N; Ermiş H; Alişkan H; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2008 Jul; 42(3):399-406. PubMed ID: 18822882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis. Chemoprophylaxis and treatment.
    McClement JH
    Postgrad Med; 1975 Sep; 58(3):97-101. PubMed ID: 1161664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.